Life sciences industry forecast for 2026 and beyond 

As we close out 2025 and look ahead to 2026, the life sciences industry faces a year defined by rapid change and new challenges. Shifting capital markets, evolving global trade and tax dynamics, emerging regulatory and assurance trends, and heightened governance and risk expectations are reshaping the landscape. Organizations must navigate these complexities while pursuing growth, innovation, and operational resilience. Leaders are reassessing strategies across IPOs, fundraising, tariffs, compliance and enterprise risk to stay competitive and position their organizations for success. 

Join Baker Tilly for our fifth annual life sciences industry forecast webinar, where we’ll examine the trends shaping the year ahead, including: 

• The state of IPOs, M&A activity and fundraising in a changing market. 
• Key impacts of tariffs, pricing shifts and tax updates, with guidance on government pricing and cross-border operations. 
• Emerging regulatory trends for biotech and biopharma, including assurance and SOX perspectives. 
• Strategies to manage enterprise risk, compliance and stewardship, and to enhance oversight at the board and executive level. 

Gain insight to support strategic planning, navigate uncertainty and position your organization for sustainable growth in 2026 and beyond. 

Who should attend? 

C-Suite professionals, presidents, vice presidents, management and other leaders of life sciences organizations.

Meet our team 

• Richard Croghan, Principal 
• Darren R. Jones, Principal 
• Seung Yoo, Principal 
• Pete Mento, Director 
• Arlene Chan